Text Size   +  + +

Anthrax

Surviving exposure to anthrax is a race against time. Anthrax spores are dormant when they enter the body through inhalation or the skin. Once macrophages engulf and attempt to destroy the anthrax, the spores germinate and release toxins that kill the macrophages, eventually bursting the cells and spewing forth anthrax bacteria that then infect other parts of the body. The key to survival is whether the macrophage can kill the anthrax spore before it germinates, produces the toxins, kills the macrophage and causes anthrax disease.

Preclinical studies show that both PGG Beta Glucan and OTC (over the counter) high purity Beta 1, 3-D Glucan can produce a heightened state of microbial killing capability in the macrophages. This stimulation provides macrophages an advantage in their fight against anthrax.

A series of mouse studies commissioned by the Defence R&D Canada --Suffield, whose goal is to protect Canadian military forces against chemical and biological warfare, recorded survival rates from lethal exposure to anthrax in excess of 80% using systemic (injected) beta glucan, compared with survival rates of only 20-50% in untreated animals. In addition, analysis of the anthrax remaining in the lungs of the survival animals showed that more than 90% of the beta glucan-treated animals were bacteria-free.

The most amazing thing about Beta glucan is it not a treatment for any disease or condition. Beta Glucan is an immunomodulator that has been shown to support immune system function.

newsletter_signup

Subsequent mouse-anthrax research demonstrated that both prophylactic and therapeutic oral administration of the immunomodulator Beta 1, 3-D Glucan significantly increased the survival rate of infected mice. In animals, prophylactically administered oral Beta 1, 3-D Glucan increased survival from 50% in control animals to 100% in treated animals (Figure 1). In animals, therapeutically administered oral Beta 1, 3-D Glucan increased survival from 30% in control-infected animals up to 90% in immunomodulator treated animals (Figure 2).

Definition - Anthrax is an infectious disease caused by the spore-forming bacteria called Bacillus anthracis. Infection in humans most often involves the skin (cutaneous anthrax), the gastrointestinal tract, or the lungs (inhalation anthrax).

Causes and risks - Anthrax is caused by the bacterium Bacillus anthracis. While anthrax commonly affects hoofed animals such as sheep and goats, humans may acquire this disease as well. Humans can acquire anthrax through contact with animal hides or hair, bone products, and wool, as well as contact with infected animals. Historically, the populations most at risk for anthrax include farm workers, veterinarians, and tannery and wool workers.

Anthrax is a potential agent for use as a biological weapon or bio-terrorism. While at least 17 nations are believed to have a biological weapons program, it is unknown how many nations or groups are working with anthrax. Most bio-terrorism experts have concluded that it is technologically difficult to use anthrax effectively as a weapon on a large scale. Definition from Medline Plus.

Prophylactic - To prevent or guard against disease, i.e. an attempt to avert a possible adverse health condition. The mammals in the prophylactic study (the first graph) were given Beta Force Whole Glucan Particulate beta glucan 7 days before exposure to Anthrax.

Beta Force's Beta 500's Material is Supported by Independent Preclinical and Clinical Studies Against (Click the link to review the study in detail):

Beta Force Beta 500's is not a treatment for any disease or condition. Beta Glucan is an immunomodulator that has been shown to support immune system function.